ArticleFrontiers in medicine2025
Postpartum continuous epidural analgesia on pain, sleep quality, and emotional state in childbearing women: a randomized controlled trial.
Article in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: This study aimed to explore the effects of continuous epidural analgesia on postpartum pain and sleep quality in postpartum women. Methods: First-time mothers who received labor analgesia in the obstetrics department of Changzhi People's Hospital, affiliated to Changzhi Medical College, from November 2024 to December 2024, were selected and randomly divided into the control group (C group) and the experimental group (E group). The control group received epidural labor analgesia after entering the labor process, using 10 mL of 1% ropivacaine, 50 μg of sufentanil, and 90 mL of 0.9% sodium chloride injection. The initial bolus dose was 6 mL, the injection rate was 6 mL/h, with additional doses of 4 mL each time, a lockout time of 15 min, and continuous infusion until the fetus was delivered and then stopped. The experimental group received epidural labor analgesia after entering the labor process and continued the infusion for 2 days after the fetus was delivered, with the same medication concentration and infusion rate as the control group. All postpartum mothers had blood samples taken before sleep on the 1st and 3rd days after delivery to measure serum melatonin levels. The visual analog scale (VAS) was used to compare pain scores (including sitting pain, sleep pain, and urination pain) on the 1st and 3rd days after the fetus was delivered in both groups. The modified Bromage score (MBS) was used to evaluate the mobility of the lower limbs. On the 3rd postoperative day, the Edinburgh Postnatal Depression Scale (EPDS) and the Pittsburgh Sleep Quality Index (PSQI) were used to assess sleep quality and emotional state, and the occurrence of depression in both groups. Results: The VAS scores for sitting pain, sleep pain, and urination pain on the 1st and 3rd days after the fetus was delivered were all lower in the experimental group compared to the control group ( Conclusion: The implementation of continuous epidural analgesia after childbirth can significantly alleviate postpartum pain, improve sleep quality, and reduce the occurrence of postpartum depression without affecting the mother's mobility.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.